Ultima DSIP Research Overview
DSIP is a synthetic nonapeptide originally isolated from the venous blood of sleeping rabbits. This research compound demonstrates a unique profile in sleep-wake cycle investigations and neuroendocrine pathway studies. As a specialist Stroid UK Shop, we provide high-purity DSIP for advanced laboratory investigations examining sleep regulation mechanisms and hypothalamic-pituitary-adrenal axis modulation. The nonapeptide structure consists of nine amino acids and exhibits notable stability in biological systems under research conditions.
Laboratory Research Applications
DSIP serves as a valuable research tool for investigating circadian rhythm pathways and neuromodulatory mechanisms in controlled laboratory environments. Research models have examined its effects on sleep architecture, stress hormone regulation, and temperature homeostasis. Studies utilising this peptide focus on understanding sleep-wake transitions and their underlying biochemical processes. Our DSIP peptide collection supports comprehensive sleep research protocols and neuroendocrine investigations. The compound’s unique properties make it particularly suitable for examining hypothalamic function and its role in sleep regulation. Research applications extend to investigating stress response mechanisms and their relationship with sleep patterns. Scientists studying circadian biology utilise DSIP to examine temporal regulation of physiological processes. The peptide’s stability characteristics enable extended research protocols examining long-term effects on sleep parameters. Comparative studies with other research peptides provide insights into sleep-wake regulatory networks. Advanced research models investigate DSIP’s role in temperature regulation and its connection to sleep onset mechanisms. The compound facilitates studies on stress-induced sleep disturbances and recovery processes. Research into age-related changes in sleep patterns often incorporates DSIP as a reference compound. Our extensive research chemical inventory supports multi-modal investigations combining DSIP with other regulatory compounds.
Technical Specifications
| Parameter | Value |
|---|---|
| Sequence | Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu |
| Molecular Weight | 848.81 g/mol |
| Purity | Verify with supplier |
| Form | Lyophilised powder |
| Storage | -20°C long-term, 2-8°C short-term |
| Reconstitution | Sterile water or bacteriostatic water |
| Stability | Reconstituted solution stable 30 days at 2-8°C |
Research Compliance
This DSIP preparation is manufactured by Ultima Pharmaceuticals exclusively for in-vitro research applications and laboratory investigations. Not intended for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must possess appropriate qualifications and follow institutional guidelines when handling this compound. All studies should comply with relevant laboratory safety protocols and regulatory requirements governing peptide research materials.
